The relationship between heart rate variability and serum cytokines in chronic chagasic patients with persistent parasitemia

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 6, 2011, Pages 724-735

  Llaguno, Mauricio ^a   De Resende Pertili, Luiz Antonio Rodrigues ^a   Da Silva, Marcos Vinicius ^a   Bunazar, Pablo ^a   Reges, Ariane Martim ^a   Faleiros, Ana Carolina Guimarães ^a   Lages Silva, Eliane ^a   Rodrigues Jr , Virmondes ^a   Da Silva, Valdo José Dias ^a   Filho, Dalmo Correia ^a,b  

^a FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^b NONE   (Brazil)

Author keywords

Chagas disease; dysautonomia; heart rate variability; parasitemia; serum cytokines

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYTOKINE; GAMMA GLUTAMYLTRANSFERASE; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; POTASSIUM; SODIUM; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHAGAS DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC DISEASE; CLINICAL ARTICLE; COLD FACE TEST; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; POTASSIUM BLOOD LEVEL; PROTEIN BLOOD LEVEL; SEROLOGY; SODIUM BLOOD LEVEL; THORAX RADIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; TRYPANOSOMA CRUZI; UREA BLOOD LEVEL;

EID: 79958159290     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.03025.x     Document Type: Article

References (76)

1. Dias JC, Silveira AC, Schofield CJ,. The impact of Chagas disease control in Latin America: A review. Mem Inst Oswaldo Cruz 2002; 97: 603-612. (Pubitemid 135746072)
2. Coura JR,. Transmission of chagasic infection by oral route in the natural history of Chagas disease. Rev Soc Bras Med Trop 2006; 39 (Suppl 3): 113-117.
3. Chagas C,. Nova tripanozomiase humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n.gen.,n. sp., ajente etiolojico de nova entidade mõrbida do homen. Mem Inst Oswaldo Cruz 1909; I: 5-61.
4. Prata A,. Clinical and epidemiological aspects of Chagas disease. Lancet infect Dis 2001; 1: 92-100. (Pubitemid 33586044)
5. Rassi A Jr, Rassi A, Little WC, Xavier SS, Rassi SG, Rassi AG, Rassi GG, et al,. Development and validation of a risk score for predicting death in Chagas' heart disease. New Engl J Med 2006; 355: 799-808. (Pubitemid 44285585)
6. Schmunis GA,. The globalization of Chagas disease. ISBT Sci Ser 2007; 2: 6-11.
7. Maguire JH,. Chagas' disease-can we stop the deaths? New Engl J Med 2006; 355: 760-761.
8. Brener Z, Gazzinelli RT,. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol 1997; 114: 103-110. (Pubitemid 27397063)
9. Morel CM, Lazdins J,. Chagas disease. Nat Rev Microbiol 2003; 1: 14-15.
10. Higuchi Mde L, Benvenuti LA, Martins Reis M, Metzger M,. Pathophysiology of the heart in Chagas' disease: Current status and new developments. Cardiovasc Res 2003; 60: 96-107. (Pubitemid 38373480)
11. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV,. Pathogenesis of chronic Chagas heart disease. Circulation 2007; 115: 1109-1123. (Pubitemid 46679556)
12. Cunha-Neto E, Teixeira PC, Nogueira LG, Mady C, Lanni B, Stolf N, Fiorelli A, et al,. New concepts on the pathogenesis of chronic Chagas cardiomyopathy: Myocardial gene and protein expression profiles. Rev Soc Bras Med Trop 2006; 39 (Suppl 3): 59-62.
13. Vray B, Camby I, Vercruysse V, Mijatovic T, Bovin NV, Ricciardi-Castagnoli P, Kaltner H, et al,. Up-regulation of galectin-3 and its ligands by Trypanosoma cruzi infection with modulation of adhesion and migration of murine dendritic cells. Glycobiology 2004; 14: 647-657. (Pubitemid 38923646)
14. Köberle F,. Pathology and pathological anatomy of Chagas' disease. Bol Oficina Sanit Panam 1961; 51: 404-428.
15. Lopes ER, Chapadeiro E, Andrade ZA, Almeida HO, Rocha A,. Pathological anatomy of hearts from asymptomatic Chagas disease patients dying in a violent manner. Mem Inst Oswaldo Cruz 1981; 76: 189-197.
16. Köberle F,. Chagas disease: A disease of the peripheral autonomic nervous system. Wien Klin Wochenschr 1956; 68: 333-339.
17. Miziara AN, Molina RJ, Ferreira BD, Barbosa CJ, Dias da Silva VJ, Prata A, Correia D,. Cardiac autonomic modulation in hypertensive patients with Chagas' disease. Acta tropica 2006; 97: 188-195. (Pubitemid 43087753)
18. Natelson BH, Goldwater DJ, De Roshia C, Levin BE,. Visceral predictors of cardiovascular deconditioning in late middle-aged men. Aviat Space Environ Med 1985; 56: 199-203. (Pubitemid 15146636)
19. Junqueira LF Jr, Soares JD,. Impaired autonomic control of heart interval changes to Valsalva manoeuvre in Chagas' disease without overt manifestation. Auton Neurosci 2002; 97: 59-67. (Pubitemid 34234862)
20. Marin-Neto JAB-M G, Pazin-Filho A, Simoes MV, Maciel BC,. Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol 1998; 65: 261-269. (Pubitemid 28368332)
21. Guzzetti S, Josa D, Pecis M, Bonura L, Prosdocimi M, Malliani A,. Effects of sympathetic activation on heart rate variability in Chagas' patients. J Auton Nerv Syst 1990; 30 (Supp l): S79-S81. (Pubitemid 20244729)
22. Lavadens R, Palmero E,. Bradycardia-tachycardia syndrome in chronic Chagas' cardiopathy. Arq Bras Cardiol 1984; 42: 345-350. (Pubitemid 14041370)
23. Correia D, Junqueira LF, Jr, Molina RJ, Prata A,. Cardiac autonomic modulation evaluated by heart interval variability is unaltered but subtly widespread in the indeterminate Chagas' disease. Pacing Clin Electrophysiol 2007; 30: 772-780. (Pubitemid 46850711)
24. Correia D, Miziara Ade N, Molina RJ, Ferreira BD, Barbosa CJ, da Silva VJ, Prata A,. Heart rate variability in Chagas' patients with and without hypertension. Rev Soc Bras Med Trop 2003; 36 (Suppl 2): 5-10.
25. Molina RB, Matsubara BB, Hueb JC, Zanati SG, Meira DA, Cassolato JL, Paiva SA, et al,. Dysautonomia and ventricular dysfunction in the indeterminate form of Chagas disease. Int J Cardiol 2006; 113: 188-193. (Pubitemid 44648402)
26. Oliveira E, Ribeiro AL, Assis Silva F, Torres RM, Rocha MO,. The Valsalva maneuver in Chagas disease patients without cardiopathy. Int J Cardiol 2002; 82: 49-54. (Pubitemid 34084916)
27. Oliveira L, Correia D, Miziara A, Resende LA,. Heart rate variability in chronic Chagas patients before and after treatment with benzidazole. Auton Neursci 2010; 158: 118-122.
28. Resende LA, Carneiro AC, Ferreira BD, da Silva RA, da Silva VJ, Prata A, Correia D,. Temporal analysis of cardiac frequency variability in basal condition in elderly chagasic subjects in indeterminate form in endemic area. Rev Soc Bras Med Trop 2003; 36: 703-706. (Pubitemid 38160175)
29. Resende LA, Molina RJ, Ferreira BD, Carneiro AC, Ferreira LA, da Silva VJ, Prata A, et al,. Cardiac autonomic function in chagasic elderly patients in an endemic area: A time and frequency domain analysis approach. Auton Neurosci 2007; 131: 94-101. (Pubitemid 46016972)
30. Ribeiro AL, Ferreira LM, Oliveira E, Cruzeiro PC, Torres RM, Rocha MO,. Active orthostatic stress and respiratory sinus arrhythmia in patients with Chagas' disease with preserved left ventricular global systolic function. Arq Bras Cardiol 2004; 83: 40-44; 35- 49.
31. Ribeiro AL, Gimenez LE, Hernandez CC, de Carvalho AC, Teixeira MM, Guedes VC, Barros MV, et al,. Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 2007; 117: 59-63. (Pubitemid 46431164)
32. Ribeiro AL, Lombardi F, Sousa MR, Lins Barros MV, Porta A, Costa Val Barros V, Gomes ME, et al,. Power-law behavior of heart rate variability in Chagas' disease. Am J Cardiol 2002; 89: 414-418. (Pubitemid 34142516)
33. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Torres RM, Oliveira E, Rocha MO,. Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001; 141: 260-265. (Pubitemid 32128732)
34. Sousa L, da Costa Rocha MO, Britto RR, Lombardi F, Ribeiro AL,. Chagas disease alters the relationship between heart rate variability and daily physical activity. Int J Cardiol 2009; 135: 257-259.
35. Vasconcelos DF, Junqueira LF Jr,. Distinctive impaired cardiac autonomic modulation of heart rate variability in chronic Chagas' indeterminate and heart diseases. J Electrocardio 2009; 42: 281-289.
36. Villar JC, Leon H, Morillo CA,. Cardiovascular autonomic function testing in asymptomatic T. cruzi carriers: A sensitive method to identify subclinical Chagas' disease. Int J Cardiol 2004; 93: 189-195. (Pubitemid 38232658)
37. Task-Force. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17: 354-381.
38. Morey SS,. ACC/AHA guidelines for ambulatory ECG. American College of Cardiology/American Heart Association. Am Fam Physician 2000; 61 884: 887-888.
39. Junqueira-Junior LF,. Disfunção autonômica cardíaca. In: Porto (Porto CC, ed.): Doenças do Coração Prevenção e Tratamento. Rio de Janeiro, Guanabara-Koogan, 1998; pp. 306-311.
40. Correia D,. Avaliação clínico-funcional, bioquímica e imunolõgica do sistema nervoso autônomo em residentes em área endêmica da doença de Chagas. Faculdade de Medicina. Belo Horizonte, Universidade Federal de Minas Gerais, 2000; pp. 233.
41. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D,. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol 1997; 145: 899-908. (Pubitemid 27200776)
42. Tsuji H, Venditti FJ, Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D,. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation 1994; 90: 878-883. (Pubitemid 24242758)
43. Wichterle D, Simek J, La Rovere MT, Schwartz PJ, Camm AJ, Malik M,. Prevalent low-frequency oscillation of heart rate: Novel predictor of mortality after myocardial infarction. Circulation 2004; 110: 1183-1190. (Pubitemid 39202330)
44. Tulppo M, Huikuri HV,. Origin and significance of heart rate variability. J Am Coll Cardiol 2004; 43: 2278-2280. (Pubitemid 38757598)
45. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E,. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 2000; 101: 2149-2153. (Pubitemid 30253042)
46. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH,. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101: 1767-1772. (Pubitemid 30213096)
47. Janszky I, Ericson M, Lekander M, Blom M, Buhlin K, Georgiades A, Ahnve S,. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-428. (Pubitemid 39434379)
48. Haensel A, Mills PJ, Nelesen RA, Ziegler MG, Dimsdale JE,. The relationship between heart rate variability and inflammatory markers in cardiovascular diseases. Psychoneuroendocrinology 2008; 33: 1305-1312.
49. Malliani A, Lombardi F, Pagani M,. Power spectrum analysis of heart rate variability: A tool to explore neural regulatory mechanisms. Br Heart J 1994; 71: 1-2. (Pubitemid 24061000)
50. Malik M, Camm AJ, Janse MJ, Julian DG, Frangin GA, Schwartz PJ,. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: A substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial). J Am Coll Cardiol 2000; 35: 1263-1275. (Pubitemid 30206902)
51. Chiari E, Dias JC, Lana M, Chiari CA,. Hemocultures for the parasitological diagnosis of human chronic Chagas' disease. Rev Soc Bras Med Trop 1989; 22: 19-23. (Pubitemid 20268273)
52. Camargo EP,. Growth and differentiation in Trypanosoma Cruzi. I. Origin of metacyclic trypanosomes in liquid media. Rev Inst Med Trop Sao Paulo 1964; 12: 93-100.
53. Gomes ML, Macedo AM, Vago AR, Pena SD, Galvao LM, Chiari E,. Trypanosoma cruzi: Optimization of polymerase chain reaction for detection in human blood. Exp Parasitol 1998; 88: 28-33. (Pubitemid 28375811)
54. Degrave W, Fragoso SP, Britto C, van Heuverswyn H, Kidane GZ, Cardoso MA, Mueller RU, et al,. Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi. Mol Biochem Parasitol 1988; 27: 63-70. (Pubitemid 17166826)
55. Tundo F, Lombardi F, Rocha MC, Botoni F, Schmidt G, Barros VC, Muzzi B, et al,. Heart rate turbulence and left ventricular ejection fraction in Chagas disease. Europace 2005; 7: 197-203. (Pubitemid 40614354)
56. Ribeiro AL, Schmidt G, Sousa MR, Lombardi F, Gomes ME, Perez AA, Barros MV, et al,. Heart rate turbulence in Chagas disease. Pacing Clin Electrophysiol 2003; 26: 406-410. (Pubitemid 36399182)
57. de Sousa MR, Huikuri HV, Lombardi F, Perez AA, Gomes ME, Barros MV, Barros VC, et al,. Abnormalities in fractal heart rate dynamics in Chagas disease. Ann Noninvasive Electrocardiol 2006; 11: P145-P153.
58. Goin JC, Borda ES, Auger S, Storino R, Sterin-Borda L,. Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: Association with bradycardia. Heart (Br Card Soc) 1999; 82: 273-278. (Pubitemid 29429596)
59. Pincus SM,. Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA 1991; 88: 2297-2301. (Pubitemid 21916403)
60. La Rovere MT, Schwartz PJ,. Counting heart beats: A peephole into prediction of sudden and nonsudden cardiac death. J Cardiovasc Electrophysiol 2003; 14: 174-175. (Pubitemid 36403553)
61. Maestri R, Pinna GD, Accardo A, Allegrini P, Balocchi R, D'Addio G, Ferrario M, et al,. Nonlinear indices of heart rate variability in chronic heart failure patients: Redundancy and comparative clinical value. J Cardiovasc Electrophysiol 2007; 18: 425-433. (Pubitemid 46435049)
62. Makikallio TH, Ristimae T, Airaksinen KE, Peng CK, Goldberger AL, Huikuri HV,. Heart rate dynamics in patients with stable angina pectoris and utility of fractal and complexity measures. Am J Cardiol 1998; 81: 27-31. (Pubitemid 28046837)
63. Palmero HA, Caeiro TF, Iosa D,. Prevalence of slow heart rates in chronic Chagas' disease. Am J Trop Med Hyg 1981; 30: 1179-1182. (Pubitemid 12183385)
64. Diaz JO, Makikallio TH, Huikuri HV, Lopera G, Mitrani RD, Castellanos A, Myerburg RJ, et al,. Heart rate dynamics before the spontaneous onset of ventricular tachyarrhythmias in Chagas' heart disease. Am J Cardiol 2001; 87 (A1110): 1123-1125. (Pubitemid 32710334)
65. Dutra WO, Rocha MO, Teixeira MM,. The clinical immunology of human Chagas disease. Trends Parasitol 2005; 21: 581-587. (Pubitemid 41572271)
66. Lannes-Vieira J,. Trypanosoma cruzi-elicited CD8+ T cell-mediated myocarditis: Chemokine receptors and adhesion molecules as potential therapeutic targets to control chronic inflammation? Mem Inst Oswaldo Cruz 2003; 98: 299-304. (Pubitemid 38030541)
67. Higuchi Mde L,. Chronic chagasic cardiopathy: The product of a turbulent host-parasite relationship. Rev Inst Med Trop Sao Paulo 1997; 39: 53-60.
68. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, et al,. Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 2004; 189: 909-918. (Pubitemid 38328193)
69. Albareda MC, Laucella SA, Alvarez MG, Armenti AH, Bertochi G, Tarleton RL, Postan M,. Trypanosoma cruzi modulates the profile of memory CD8+ T cells in chronic Chagas' disease patients. Int Immunol 2006; 18: 465-471. (Pubitemid 43329609)
70. D'Avila DA, Guedes PM, Castro AM, Gontijo ED, Chiari E, Galvao LM,. Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease. Mem Inst Oswaldo Cruz 2009; 104: 100-105.
71. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, et al,. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 2001; 17: 99-107. (Pubitemid 32751886)
72. Correa-Oliveira R, Gomes J, Lemos EM, Cardoso GM, Reis DD, Adad S, Crema E, et al,. The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 1999; 94 (Suppl 1): 253-255. (Pubitemid 129584504)
73. Ribeirao M, Pereira-Chioccola VL, Renia L, Augusto Fragata Filho A, Schenkman S, Rodrigues MM,. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol 2000; 22: 49-53. (Pubitemid 30098817)
74. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, Correa-Oliveira R,. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 2003; 71: 1185-1193. (Pubitemid 36254300)
75. Perez-Fuentes R, Lopez-Colombo A, Ordonez-Toquero G, Gomez-Albino I, Ramos J, Torres-Rasgado E, Salgado-Rosas H, et al,. Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis). Ann Trop Med Parasitol 2007; 101: 123-132. (Pubitemid 47488160)
76. Ward LS, Guariento ME, Fernandes GA, Maciel RM,. Serum cytokines in chronic Chagas' disease. Rev Soc Bras Med Trop 1999; 32: 285-289.